Valuation
Is the price right?Insufficient data
Insufficient data: 1 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Bringing the fundamentals into focus…
SY HealthcareBeta data
So-Young International Inc.
$1.99+0.00%
Price as of close on Nov 3, 2026 · Financials updated Oct 1, 2026
Basics
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- China
- Market cap
- 200.2M USD
- Enterprise value
- 138.0M USD
- Full-time employees
- 2,348
Growth
Is it growing?46/100
Moderate
2/3 inputs reported · Partial data
Since last year: ▲ Stronger
- 12-month revenue up 3.9%
Why
Compare with peers Close to the peer norm on every measure.
Behind the score
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
Earnings per share growthUnavailable
Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0976 · MAD: 0.29913-year revenue growth6.6%
SEC filings · 3 years to Dec 2025Reported value33% base weight · Z-score 0.09Sector median: 0.0584 · MAD: 0.0840Revenue growth3.9%
SEC filings · 12 months to Dec 2025Reported value33% base weight · Z-score -0.23Sector median: 0.0609 · MAD: 0.0974Profitability
Does it earn well?26/100
Weak
3/3 inputs reported · High confidence
Since last year: ▲ Stronger
- Operating margin rose 23.8 points to -18.8%
Why
Compare with peers Weaker than most peers on:
- ▼ ROIC
- ▼ Operating margin
- ▼ ROA
Behind the score
Return on invested capital, operating margin, and return on assets.
Operating margin-18.8%
SEC filings · 12 months to Dec 2025Reported value33% base weight · Z-score -2.12Sector median: 0.0706 · MAD: 0.1217Return on assets-9.1%
SEC filings · 12 months to Dec 2025Reported value33% base weight · Z-score -2.01Sector median: 0.0166 · MAD: 0.0537Return on invested capital-19.9%
SEC filings · 12 months to Dec 2025Reported value33% base weight · Z-score -2.45Sector median: 0.0471 · MAD: 0.1004Other data (not scored)
Gross margin46.0%
Yahoo Finance · trailing 12 monthsReported valueInformational · 0% composite weightSector median: 0.4697 · MAD: 0.2310Return on equity-15.0%
Yahoo Finance · trailing 12 monthsReported valueInformational · 0% composite weightSector median: 0.0330 · MAD: 0.1225Risk
Debt, liquidity, price swingsHigher
Higher relative risk
3/3 inputs reported · High confidence
Since last year: No major change
Why
Compare with peers Weaker than most peers on:
- ▼ Beta
- ▼ Current ratio
Behind the score
Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.
Beta2.13
Yahoo Finance · 5-year monthly beta vs the marketOutlier capped at sector 5th/95th percentile33% base weight · Z-score -4.28Sector median: 0.6250 · MAD: 0.3380Current ratio1.73×
Yahoo FinanceReported value33% base weight · Z-score -0.62Sector median: 2.5860 · MAD: 1.3850Debt / equity0.24×
Yahoo FinanceReported value33% base weight · Z-score -0.07Sector median: 0.2215 · MAD: 0.2039Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about So-Young International
- Is So-Young International getting weaker?
- Its latest SEC filing (Apr 23, 2026) got stronger: operating margin rose 23.8 points to -18.8%. Its overall score is unchanged at 30/100 since Oct 28, 2026.
- How is So-Young International valued vs its peers?
- Insufficient data: 1 of 3 inputs reported (at least 2 needed).
- Is So-Young International growing?
- At about the same pace as its peers. Growth scores 46/100 against 1,393 healthcare peers.
- How profitable is So-Young International?
- Less profitable than most of its peers. Profitability scores 26/100 against 1,393 healthcare peers. Return on invested capital -19.9% vs a peer median of 4.7% (weaker than 79% of peers).Return on invested capital -19.9% vs peers 4.7% (weaker than 79% of peers).
- How risky is So-Young International?
- Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Beta 2.13 vs a peer median of 0.63 (weaker than 100% of peers).Beta 2.13 vs peers 0.63 (weaker than 100% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Year ended Dec 31, 2025 · filed Apr 23, 2026 · compared with the year ended Dec 31, 2024Got stronger
- Operating margin rose 23.8 points to -18.8%
| Previous year | Latest year | Change | |
|---|---|---|---|
| Revenue (12 months) | 1.5B CNY | 1.5B CNY | +3.9% |
| Net income (12 months) | −589.5M CNY | −242.3M CNY | −58.9% |
| Operating margin | -42.6% | -18.8% | +23.8 pts |
| Free cash flow (12 months) | −88.2M CNY | −302.0M CNY | +242.5% |
| Cash | 587.7M CNY | 418.2M CNY | −28.8% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one year at a time.
Financials
Fiscal years from SEC annual filings · change vs the prior year · amounts in CNY, as reported| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Gross margin | 80.6% | 68.7% | 63.7% | 61.3% | 47.8% | ▼ 14 pts |
| Operating margin | -1.9% | -8.2% | -4.1% | -42.6% | -18.8% | ▲ 24 pts |
| Net margin | -0.5% | -5.2% | 1.4% | -40.2% | -15.9% | ▲ 24 pts |
| Return on assets (ROA) | -0.3% | -2.0% | 0.7% | -21.6% | -9.1% | ▲ 12 pts |
| Return on equity (ROE) | -0.3% | -2.6% | 0.9% | -32.1% | -15.6% | ▲ 16 pts |
| Free cash flow margin | 2.3% | -10.2% | -1.9% | -6.0% | -19.8% | ▼ 14 pts |
| Current ratio | 2.85× | 3.56× | 3.19× | 2.74× | 1.89× | ▼ 31% |
| Quick ratio | 2.72× | 3.34× | 2.97× | 2.50× | 1.60× | ▼ 36% |
| Debt to equity | — | — | 0.01× | 0.04× | 0.03× | ▼ 32% |
SY price history
Price history is added with the daily price update and will appear after the next one.